DeepCure
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $65M
Investors
- 6
About DeepCure
Based in Massachusetts, US, and co-founded by Kfir Schreiber (CEO), Joseph Jacobson (CSO), and Thrasyvoulos (Thras) Karydis (CTO) in 2018, DeepCure, Inc. operates as a Biotechnology research company offering an artificial intelligence (AI) based engine for the AI-driven small-molecule drugs development., Morningside Venture Partners, Sapir Venture Partners, and TLV Partners. The company through advanced technology optimizes all phases of drug discovery, from hit identification to lead optimization and beyond. The DeepCure’s portfolio includes Binding Modeling, PocketExpander™, and MolGen™, which enable the creation of precise, human-interpretable hypotheses, design of diverse compounds, and prediction of important pharmacological properties, across different therapeutic indications. DeepCure's approach ensures better molecules and faster cures, aiming to discover, develop, and deliver small-molecule drugs. Some of the products in the company’s pipeline include Brd4 for oral systemic, cutaneous, and ophthalmic indications, undisclosed transcription factors for inflammation or immune indications, etc.
Who invested in DeepCure
6 investors across 3 rounds
See all investors in DeepCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DeepCure
Who invested in DeepCure?
DeepCure has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DeepCure raised?
DeepCure has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did DeepCure last raise money?
DeepCure's most recent round on record is a Series A, in Apr 2024.
What does DeepCure do?
Based in Massachusetts, US, and co-founded by Kfir Schreiber (CEO), Joseph Jacobson (CSO), and Thrasyvoulos (Thras) Karydis (CTO) in 2018, DeepCure, Inc.
Where is DeepCure headquartered?
DeepCure is headquartered in Boston, US.
Which VCs invest in companies like DeepCure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DeepCure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DeepCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.